Table 3.
Number of affected patients | Before surgery | Last follow‐up | % Improvement | p * | ||
---|---|---|---|---|---|---|
BFMDRS | Total | 20 | 14.6 ± 10.2 | 3.8 ± 8.2 | 74.00% | <0.0001 |
Right side | ||||||
Arm | 4 | 11.3 ± 3.6 | 0.7 ± 1.2 | 93.80% | 0.068 | |
Leg | 0 | – | – | |||
Left side | ||||||
Arm | 4 | 8 ± 1.4 | 2.3 ± 4.5 | 71.30% | 0.109 | |
Leg | 1 | 12 | 0 | 100% | 0.317 | |
Midline | ||||||
Eyes | 8 | 6.3 ± 1.3 | 3.3 ± 3.4 | 47.60% | 0.026 | |
Mouth | 6 | 4.3 ± 2.0 | 2.4 ± 3.3 | 44.20% | 0.039 | |
Speech/swallow | 7 | 4.0 ± 1.6 | 1.2 ± 1.6 | 70.00% | 0.026 | |
Neck | 16 | 5.2 ± 2.0 | 0.9 ± 1.7 | 73.10% | <0.001 | |
Trunk | 4 | 5.0 ± 2.6 | 1.5 ± 3 | 70.00% | 0.109 | |
Follow‐up period (month) | 23.6 ± 12.2 | |||||
Interval between staged surgeries (month) | 8.2 ± 3.8 |
Data are presented as mean ± standard deviation.
BFMDRS, Burke‐Fahn‐Marsden Dyatonia Rating Scale.
Wilcoxon signed‐rank test.